C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?
- PMID: 33778886
- PMCID: PMC8083631
- DOI: 10.1093/eurheartj/ehab169
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?
Figures
Comment on
-
C-reactive protein and clinical outcomes in patients with COVID-19.Eur Heart J. 2021 Jun 14;42(23):2270-2279. doi: 10.1093/eurheartj/ehaa1103. Eur Heart J. 2021. PMID: 33448289 Free PMC article.
References
-
- Abernethy TJ, Avery OT.. The occurrence during acute infections of a protein not normally present in the blood. I. Distribution of the reactive protein in patient’s sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J Exp Med 1941;73:173–182. - PMC - PubMed
-
- Volanakis JE, Kaplan MH.. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 1971;136:612–614. - PubMed
-
- Kaplan MH, Volanakis JE.. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 1974;112:2135–2147. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
